The partnership means that Apple's fitness and wellness service will be made available to all members who enrol onto ...

A new study has revealed what could be happening to your muscles after taking Ozempic, though clinical trials are needed to test on humans ...

Two studies were conducted to verify concerns about diabetic retinopathy that were raised during initial trials of ...

SOON after losing 4st with skinny jabs, Jane Fennah’s eyes turned yellow – and she needed an organ removed. “I thought I was ...

Researchers suggest all diabetes patients on weight-loss drugs should be regularly screened and monitored for potential eye ...

Leaders at Eli Lilly believe heavy investment in the company's manufacturing footprint “sets a high standard that newcomers ...

SALT LAKE CITY — It was a first-of-its-kind study conducted at the University of Utah on a drug that has, to date, changed ...

Scholar Rock Holding Corporation (NASDAQ:SRRK) is among the 11 Best GLP-1 and Weight Loss Stocks to Invest in.

Novo Nordisk A/S (NYSE:NVO) is among the. Novo Nordisk A/S (NYSE:NVO) lowered its operating profit growth projections to 10–16% (from 16-24%) and revenue growth projections to 8-14% (from 13-21%) at ...

Many people around the world are turning to new prescription drugs to help them lose weight. These medicines can work very well while you are taking them, but a new study suggests that the weight loss ...

A warning about weight loss drugs and potential eye damage. Using GLP-1 medications is associated with an increased risk for ...

People who took the daily pill orforglipron lost 12 percent of body weight on average after 72 weeks, according to clinical trial results from Lilly.